The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial. Read more about The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial.
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer Read more about Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy Read more about A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) Read more about A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Post-op Outcomes of Enhanced Energy Delivery Dissection for Mastectomy With Immediate Breast Reconstruction Read more about Post-op Outcomes of Enhanced Energy Delivery Dissection for Mastectomy With Immediate Breast Reconstruction
Phase I Study of Fractionated Stereotactic Radiation Therapy Read more about Phase I Study of Fractionated Stereotactic Radiation Therapy
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Read more about Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer Read more about Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
Family Groups for Urban Youth With Disruptive Behavior Read more about Family Groups for Urban Youth With Disruptive Behavior
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer Read more about S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer